Most immune biomarkers in the tumor were correlated with the inflamed immune microenvironment, such as enhanced chemokines, MHC molecules, and effective TIICs, and also correlated with immune checkpoint expressions [30, 31]. This evidence concerns the gene HLA-C and neoplasm.